The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
5041732 5821946 F 1 5041732-4 20050530 20060627 20060630 EXP HQWYE137402JUN05 WYETH CONSUMER HEALTHCARE 78 YR F N 72.64 KG 20060628 UNITED STATES

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
5041732 1007435641 PS AXID AR 1 ORAL 1 TABLET 1X PER 1 DAY, ORAL Y D 20555
5041732 1007457385 C XANAX 1

Indications of drugs used

Event ID DRUG SEQ INDI PT
5041732 1007435641 GASTROOESOPHAGEAL REFLUX DISEASE

Outcome of event

Event ID OUTC COD
5041732 OT

Reactions reported

Event ID PT
5041732 DIZZINESS
5041732 DRUG INEFFECTIVE
5041732 GINGIVAL SWELLING
5041732 OEDEMA MOUTH
5041732 SWELLING FACE
5041732 THROAT TIGHTNESS

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID RPSR COD
5041732 CSM

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
5041732 1007435641 20050530 20050530